Results
1
-
10
of
95
<
1
2
3
...
9
10
>
[DOI: 10.1021/jm100146h]
Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.
,
American Journal of Cardiovascular Drugs
[DOI: 10.1007/s40256-016-0204-1]
Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan.
,
Clinical Drug Investigation
[DOI: 10.1007/s40261-016-0487-7]
Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China.
,
Advances in Therapy
[DOI: 10.1007/s12325-016-0460-0]
A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery.
,
Archives of Orthopaedic and Trauma Surgery
[DOI: 10.1007/s00402-017-2697-8]
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences.
,
BMC Health Services Research
[DOI: 10.1186/s12913-017-1995-8]
Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.
,
Journal of Thrombosis and Thrombolysis
[DOI: 10.1007/s11239-017-1495-z]
Effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement.
,
Journal of Thrombosis and Thrombolysis
[DOI: 10.1007/s11239-017-1492-2]
Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China.
,
Clinical Drug Investigation
[DOI: 10.1007/s40261-016-0444-5]
Left atrium mass in a patient with breast cancer: a case report.
,
Journal of Medical Case Reports
[DOI: 10.1186/s13256-016-1079-0]
<
1
2
3
...
9
10
>